Eradication of H. pylori with Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration

Background. The study was conducted to compare the efficacy and tolerability of two pantoprazole‐based triple therapies of different length in the eradication of H. pylori.

[1]  N. Vakil,et al.  Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. , 1996, The American journal of gastroenterology.

[2]  D. Tompkins,et al.  Failed Treatment of Helicobacter pylori Infection Associated with Resistance to Clarithromycin , 1997, Helicobacter.

[3]  N. Talley,et al.  Is Helicobacter pylori a cause of nonulcer dyspepsia. , 1996, Digestive diseases and sciences.

[4]  R. Hunt,et al.  Adding Once-Daily Omeprazole 20 mg to Metronidazole/Amoxicillin Treatment for Helicobacter pylori Gastritis: A Randomized, Double-Blind Trial Showing the Importance of Metronidazole Resistance , 1998, American Journal of Gastroenterology.

[5]  B. Collins,et al.  Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up , 1994, The Lancet.

[6]  J. Wood,et al.  Ranitidine and cimetidine in the healing of duodenal ulcer: meta‐analysis of comparative clinical trials , 1987, Alimentary pharmacology & therapeutics.

[7]  A. Goddard,et al.  Antimicrobial resistance and Helicobacter pylori. , 1996, The Journal of antimicrobial chemotherapy.

[8]  A. Mentis,et al.  Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patterns. , 1996, Gut.

[9]  I. M. Davis,et al.  Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate. , 1996, British journal of clinical pharmacology.

[10]  P D Klein,et al.  Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal Ulcer , 1992, Annals of Internal Medicine.

[11]  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. , 1997, Gut.

[12]  J. L. Taylor,et al.  Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. , 1997, Archives of internal medicine.

[13]  W. Atoyebi,et al.  Rapid eradication of Helicobacter pylori infection , 1995, Alimentary pharmacology & therapeutics.

[14]  B. C. Wong,et al.  Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. , 1997, Gut.

[15]  J. Misiewicz,et al.  The Sydney System: A new classification of gastritis. Introduction , 1991, Journal of gastroenterology and hepatology.

[16]  A. Peters.  Development of radiolabelled white cell scanning. , 1994, Scandinavian journal of gastroenterology. Supplement.

[17]  M. Bateson.  One week triple therapy for Helicobacter pylori , 1998, Gut.

[18]  C. Pennington.  Review article: towards safer parenteral nutrition , 1990, Alimentary pharmacology & therapeutics.

[19]  Colombo,et al.  Comparison of omeprazole and lansoprazole in short‐term triple therapy for Helicobacter pylori infection , 1998, Alimentary pharmacology & therapeutics.

[20]  B. C. Wong,et al.  Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. , 1996, Gut.

[21]  A. Axon,et al.  Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. , 1995, European journal of gastroenterology & hepatology.

[22]  P. Mainguet,et al.  [The "Sidney System", a new classification of gastritis]. , 1993, Gastroenterologie clinique et biologique.

[23]  A. Li,et al.  Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. , 1995, The New England journal of medicine.

[24]  K. Goh,et al.  Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori—a randomized, double‐blind comparison of a three times daily and twice daily regimen , 1997, European journal of gastroenterology & hepatology.

[25]  J. Tjandra,et al.  Helicobacter pylori in peptic ulcer disease. , 1995, The Australian and New Zealand journal of surgery.

[26]  B. Moum,et al.  Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? , 1997, The American journal of gastroenterology.

[27]  A. Berstad,et al.  Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. , 1994, Scandinavian journal of gastroenterology.

[28]  R. Spiller,et al.  Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study , 1996, Helicobacter.

[29]  A. Sonnenberg.  Costs of medical and surgical treatment of duodenal ulcer. , 1989, Gastroenterology.

[30]  H. DeK. Grundling,et al.  Two‐week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing , 1998, Alimentary pharmacology & therapeutics.

[31]  Derek F. J. Brown,et al.  Evaluation of the E test, a novel method of quantifying antimicrobial activity. , 1991, The Journal of antimicrobial chemotherapy.

[32]  B. O'brien,et al.  Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. , 1995, Archives of internal medicine.

[33]  M. Stolte,et al.  One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. , 1995, European journal of gastroenterology & hepatology.

[34]  R. V. D. van der Hulst,et al.  The management of H pylori infection , 1998, BMJ.

[35]  E. Rauws,et al.  Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials , 1994 .

[36]  C. O'Morain,et al.  Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer , 1993 .

[37]  B. Jaup,et al.  Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. , 1995, The American journal of gastroenterology.

[38]  M. Walker,et al.  Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection , 1996, Alimentary pharmacology & therapeutics.

[39]  M. Stolte,et al.  [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. , 1995, Leber, Magen, Darm.

[40]  A. Burette,et al.  Evaluation of various multi-drug eradication regimens for Helicobacter pylori , 1992 .

[41]  D. Graham,et al.  Changes in the gastric mucosa following eradication of Helicobacter pylori. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[42]  R. Cebul,et al.  A Cost Analysis of Alternative Treatments for Duodenal Ulcer , 1995, Annals of Internal Medicine.

[43]  A. Thomson,et al.  Helicobacter pylori: Basic Mechanisms to Clinical Cure , 1995 .

[44]  F. Bazzoli,et al.  Short‐term low‐dose triple therapy for the eradication of Helicobacter pylori , 1994 .

[45]  A. Gad,et al.  Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients , 1993 .

[46]  P. Sipponen,et al.  Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. , 1991, Scandinavian journal of gastroenterology.

[47]  T. Borody,et al.  Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication , 1989, The Medical journal of Australia.

[48]  A. Axon.  Eradication of Helicobacter pylori. , 1996, Scandinavian journal of gastroenterology. Supplement.

[49]  C. O'Morain,et al.  One week triple therapy for Helicobacter pylori: a multicentre comparative study , 1997, Gut.

[50]  H. Zanen,et al.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. , 1988, Gastroenterology.

[51]  B. Marshall,et al.  Pyloric Campylobacter infection and gastroduodenal disease , 1985, The Medical journal of Australia.

[52]  R. Genta,et al.  Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection , 1995, Alimentary pharmacology & therapeutics.

[53]  D. Jaspersen.  Helicobacter pylori eradication: the best long-term prophylaxis for ulcer bleeding recurrence? , 1995, Endoscopy.

[54]  G. Porro,et al.  Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. , 1994, Scandinavian journal of gastroenterology. Supplement.

[55]  Fred E. Silverstein,et al.  Helicobacter pylori in peptic ulcer disease. , 1994, NIH consensus statement.

[56]  F. Mégraud.  H. pylori resistance to antibiotics , 1994 .

[57]  R. Hunt,et al.  Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance. , 1998 .

[58]  Guido N. J. Tytgat,et al.  Campylobacter pyloridis-associated chronic active antral gastritis. , 1988 .

[59]  J. H. Baron,et al.  One week eradication regimen for Helicobacter pylori , 1991, The Lancet.

[60]  E Hentschel,et al.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. , 1993, The New England journal of medicine.

[61]  H. Rautelin,et al.  Role of metronidazole resistance in therapy of Helicobacter pylori infections , 1992, Antimicrobial Agents and Chemotherapy.

[62]  M. Stolte,et al.  Efficacy and tolerability of a one‐week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer , 1997, Alimentary pharmacology & therapeutics.

[63]  K. Wormsley,et al.  Review article: maintenance treatment with H2‐receptor antagonists for peptic ulcer disease , 1992, Alimentary pharmacology & therapeutics.

[64]  J. Loane,et al.  One Week Triple Therapy for Helicobacter pylori: Does High‐dose Clarithromycin Confer Additional Benef it? , 1997, Helicobacter.

[65]  K. Jaskiewicz,et al.  Long‐term histologic consequences of suppression/eradication of Helicobacter pylori in antral mucosa , 1993 .

[66]  C. O'Morain,et al.  Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. , 1996, The Journal of antimicrobial chemotherapy.

[67]  L. Laine,et al.  Randomized comparison of differing periods of twice‐a‐day triple therapy for the eradication of Helicobacter pylori , 1996, Alimentary pharmacology & therapeutics.

[68]  M. Lazzaroni,et al.  Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone. , 1993, Gut.

[69]  J. Trowell,et al.  Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistance , 1992, Alimentary pharmacology & therapeutics.

[70]  D. Graham,et al.  Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. , 1993, Scandinavian journal of gastroenterology.

[71]  S. W. Hosking,et al.  Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial , 1994, The Lancet.